Researchers in India provided new insights on the complex nature of drug-induced movement disorders (DIMDs) at the MDS 2022 conference.
“DIMDs form an important treatable subgroup of movement disorder, which despite conferring a significant iatrogenic burden tend to be under-recognized and inappropriately managed,” the researchers noted.